Powder: -20°C for 3 years | In solvent: -80°C for 1 year
SNAP 94847 (SNAP-94847) 是一种选择性黑色素浓缩激素受体1 拮抗剂,Ki 为 2.2 nM。它具有抗焦虑和抗抑郁活性,可减少小鼠的食物摄入。 在相同实验条件下,摩尔浓度相同的化合物盐形式与游离态具有相同的生物活性,但盐形式 SNAP 94847 hydrochloride 的水溶性和稳定性通常比游离态更好。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
25 mg | ¥ 5,130 | 6-8周 | ||
50 mg | ¥ 6,670 | 6-8周 | ||
1 mL * 10 mM (in DMSO) | ¥ 1,870 | 6-8周 |
SNAP 94847 的其他形式现货产品:
产品描述 | SNAP 94847 (SNAP-94847) is a selective and competitive MCH1 receptor (MCH1-R) antagonist (Ki: 2.2 nM). It has anxiolytic and antidepressant activity and reduces food intake in mice. |
靶点活性 | MCH1 receptor:2.2 nM (Ki, cell free) |
体外活性 | SNAP-94847 showed a favorable combination of MCH1 receptor affinity (Ki: 2.2 nM) and human R1A receptor (>80-fold) and D2 (>500-fold) selectivity [1]. |
体内活性 | SNAP-94847 (10 mg/kg, p.o.) had no effect on basal water consumption measured over 2 h: vehicle-treated (2.0 mL); 16g-treated (2.3 mL). MCH-evoked water intake was inhibited significantly by SNAP-94847 at doses of 1.0, 2.5, and 10 mg/kg [1]. BALB/c mice treated for 21 days with fluoxetine or SNAP 94847 (20 mg/kg/day) showed marked increases in quinpirole-induced locomotor activity, with the onset of hyper-locomotion appearing earlier in the time course after SNAP 94847 compared to fluoxetine. Administration of either compound for 7 days was also sufficient to augment the quinpirole response in BALB/c mice [2]. The intra-locus coeruleus and intracerebroventricular injections of melanin-concentrating hormone and chronic injections of corticosterone increased immobility time in the forced swim test and decreased sucrose preference in the sucrose preference test. All these depressive-like behaviors were reversed by an intra-locus coeruleus microinjection of SNAP-94847 [3]. |
动物实验 | Chronically treated Sprague–Dawley rats were administered fluoxetine (18 mg/kg/day) or SNAP 94847 (20 mg/kg/day) via oral gavage in 20% beta-cyclodextrin for 2 weeks (1 injection, 6 h into light cycle). For acute treatment, drugs were given orally in 20% betacyclodextrin 1 h before testing. On each test day, locomotor activity was recorded during a 60 min habituation to the novel locomotor cage, after which the rats were administered quinpirole (0.3 mg/kg, i.p.) and returned immediately to the cage, where locomotor activity was measured for an additional 180 min. In each case-control animals were administered the corresponding vehicle, without drug [2]. |
别名 | SNAP-94847 |
分子量 | 478.57 |
分子式 | C29H32F2N2O2 |
CAS No. | 487051-12-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 20 mg/mL (41.79 mM)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 2.0896 mL | 10.4478 mL | 20.8956 mL | 52.239 mL |
5 mM | 0.4179 mL | 2.0896 mL | 4.1791 mL | 10.4478 mL | |
10 mM | 0.209 mL | 1.0448 mL | 2.0896 mL | 5.2239 mL | |
20 mM | 0.1045 mL | 0.5224 mL | 1.0448 mL | 2.6119 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
SNAP 94847 487051-12-7 Endocrinology/Hormones GPCR/G Protein GPR Melanin-concentrating Hormone Receptor (MCHR) inhibit Antidepressant SNAP-94847 MCHR1 (GPR24) Melanin concentrating hormone receptor 1 Inhibitor SNAP94847 anxiolytic anxiety inhibitor